The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying
If you're an athlete worried about WADA, both are prohibited either way
[PMID: 4326911] PubMed record related to this compound for laboratory literature review
Repeated injections of DSIP in a 35-year-old male narcoleptic investigated the effects of the neuropeptide on these very symptoms and concluded that DSIP reduced the frequency of daytime sleep attacks and increased the individual's daytime performance in terms of overall alertness and activity
Sequential measurements were made of muscle strength (one repetition maximum), body composition (dual energy x-ray absorptiometry), and circulating levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3
It is not optional, and it is not a conservative estimate